COVID-19 LEGAL RESOURCE GUIDE

Explore our thought leadership on important issues and trends.

Show Filters
See Related Results In:

Perspectives

  • Announcements
    Oct. 18, 2023
    Benchmark Litigation 2024 Recognizes Kramer Levin
  • Announcements
    Sept. 22, 2023
    2023 New York Super Lawyers and Rising Stars Lists Include Over 90 Kramer Levin Attorneys
  • Announcements
    June 01, 2023
    Chambers USA 2023 Recognizes Kramer Levin
  • Articles
    Jan. 20, 2023
    SCOTUS Case With Implications for Attorney-Client Privilege Between CIPOs and C-Suite
  • Articles
    Jan. 10, 2023
    Exploring The Amgen Genus Claims Headed To High Court
  • Defining Matters
    Nov. 18, 2022
    Kramer Levin Files SCOTUS Amicus Brief on Behalf of NYIPLA Supporting Privilege Protection for Dual-Purpose Communications
  • Announcements
    Oct. 06, 2022
    Benchmark Litigation 2023 Recognizes Kramer Levin
  • Announcements
    June 23, 2022
    Managing IP Recognizes Kramer Levin’s Intellectual Property Practice and Lawyers
  • Announcements
    June 01, 2022
    Chambers USA 2022 Recognizes Kramer Levin

Events

  • Speaking Engagement
    March 20, 2024
    American Conference Institute’s 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
  • Speaking Engagement
    June 27, 2023
    American Conference Institute’s Biosimilars & Innovator Biologics 2023
  • Speaking Engagement
    March 21, 2023
    American Conference Institute’s National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies
  • Speaking Engagement
    Nov. 09, 2022
    New York Intellectual Property Law Association’s One-Day Patent CLE Seminar
  • Speaking Engagement
    June 22, 2021
    American Conference Institute’s Biosimilars & Innovator Biologics
  • Seminar
    May 19, 2021
    Kramer Levin Webinar: IPRs in 2021 — Key Strategies in a Changed Environment
  • Speaking Engagement
    June 24, 2019
    American Conference Institute’s 10th Annual Summit on Biosimilars